Peter Elfferich

1.5k total citations
21 papers, 956 citations indexed

About

Peter Elfferich is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Peter Elfferich has authored 21 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Genetics and 5 papers in Oncology. Recurrent topics in Peter Elfferich's work include Virus-based gene therapy research (4 papers), Tuberous Sclerosis Complex Research (3 papers) and Genomics and Phylogenetic Studies (3 papers). Peter Elfferich is often cited by papers focused on Virus-based gene therapy research (4 papers), Tuberous Sclerosis Complex Research (3 papers) and Genomics and Phylogenetic Studies (3 papers). Peter Elfferich collaborates with scholars based in Netherlands, United Kingdom and United States. Peter Elfferich's co-authors include Mark Nellist, Ite A. Laird‐Offringa, Dicky Halley, Bernard A. Zonnenberg, Anneke Maat‐Kievit, Miriam Goedbloed, Őzgür Sancak, Senno Verhoef, Carine Wouters and Ans van den Ouweland and has published in prestigious journals such as Nucleic Acids Research, Molecular and Cellular Biology and Journal of Virology.

In The Last Decade

Peter Elfferich

21 papers receiving 930 citations

Peers

Countries citing papers authored by Peter Elfferich

Since Specialization

Citations

This map shows the geographic impact of Peter Elfferich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Elfferich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Elfferich more than expected).

Fields of papers citing papers by Peter Elfferich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Elfferich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Elfferich. The network helps show where Peter Elfferich may publish in the future.

Co-authorship network of co-authors of Peter Elfferich

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Elfferich. A scholar is included among the top collaborators of Peter Elfferich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Elfferich. Peter Elfferich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome 2023 ·Human Mutation ·Hannie Douben, Marianne Hoogeveen‐Westerveld, Mark Nellist, (unknown), (unknown), (unknown), (unknown), Leontine van Unen, Peter Elfferich, (unknown), Yolande van Bever, Margreethe van Vliet, Rianne Oostenbrink, Jasper J. Saris, Anja Wagner, Yvette van Ierland, Tjakko J. van Ham, Rick van Minkelen	2
2	Functional and structural analyses of novel Smith-Kingsmore Syndrome-Associated MTOR variants reveal potential new mechanisms and predictors of pathogenicity 2021 ·PLoS Genetics ·Aaron D. Besterman, Thorsten Althoff, Peter Elfferich, (unknown), (unknown), Jonathan A. Bernstein, Yvette van Ierland, (unknown), Mark Nellist, Jeff Abramson, Julián A. Martínez-Agosto	9
3	Comparison of the functional and structural characteristics of rare TSC2 variants with clinical and genetic findings 2019 ·Human Mutation ·(unknown), (unknown), (unknown), (unknown), (unknown), Peter Elfferich, Gerben Schaaf, Annegien Kenter, Daniel Kümmel, Nicola Migone, Sue Povey, Rosemary Ekong, Mark Nellist	18
4	Complete APTX deletion in a patient with ataxia with oculomotor apraxia type 1 2015 ·BMC Medical Genetics ·Rick van Minkelen, Míriam Guitart, (unknown), Grace Yoon, Peter Elfferich, (unknown), (unknown), Raoul van de Graaf, Ans M.W. van den Ouweland	3
5	Variable Loss of Functional Activities of Androgen Receptor Mutants in Patients with Androgen Insensitivity Syndrome 2013 ·Sexual Development ·Peter Elfferich, Martin E. van Royen, Dennis J. van de Wijngaart, Jan Trapman, Stenvert L. S. Drop, Erica L T van den Akker, Scott J. Lusher, (unknown), Trevor Bunch, Ieuan A. Hughes, Adriaan B. Houtsmuller, Martine Cools, Sultana MH Faradz, Peter H. Bisschop, Mathijs C. Bunck, Wilma Oostdijk, Hennie T. Brüggenwirth, Albert O. Brinkmann	8
6	Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations 2011 ·Neurogenetics ·Peter Elfferich, M.C.T. Verleun-Mooijman, J A Maat-Kievit, Bart P.C. van de Warrenburg, Wilson F. Abdo, (unknown), Klaus L. Leenders, A. Hovestadt, Jan Zijlmans, (unknown), John C. van Swieten, Agnita J.W. Boon, Klaartje van Engelen, Corien C. Verschuuren‐Bemelmans, Saskia A.J. Lesnik Oberstein, Cristina Tassorelli, Leonardo Lopiano, Vincenzo Bonifati, Dennis Dooijes, Rick van Minkelen	17
7	Characterisation of TSC1 promoter deletions in tuberous sclerosis complex patients 2010 ·European Journal of Human Genetics ·Ans M.W. van den Ouweland, Peter Elfferich, Bernard A. Zonnenberg, Willem F. Arts, Tjitske Kleefstra, (unknown), José M. Millán, (unknown), Anneke Maat‐Kievit, Dicky Halley	9
8	Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis 2010 ·Familial Cancer ·Ans M.W. van den Ouweland, Peter Elfferich, R. J. Lamping, Raoul van de Graaf, (unknown), (unknown), Arjan C. Houweling	22
9	Functional Analysis of Novel Androgen Receptor Mutations in a Unique Cohort of Indonesian Patients with a Disorder of Sex Development 2009 ·Sexual Development ·Peter Elfferich, Achmad Zulfa Juniarto, Hendrikus J. Dubbink, Martin E. van Royen, Michel Molier, Jos W. Hoogerbrugge, Adriaan B. Houtsmuller, Jan Trapman, (unknown), Frank H. de Jong, Stenvert L. S. Drop, Sultana MH Faradz, Hennie T. Brüggenwirth, Albert O. Brinkmann	7
10	Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype – phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex 2005 ·European Journal of Human Genetics ·Őzgür Sancak, Mark Nellist, Miriam Goedbloed, Peter Elfferich, Carine Wouters, Anneke Maat‐Kievit, Bernard A. Zonnenberg, Senno Verhoef, Dicky Halley, Ans van den Ouweland	344
11	High level expression and secretion of truncated forms of herpes simplex virus type 1 and type 2 glycoprotein D by the methylotrophic yeast Pichia pastoris 2002 ·Protein Expression and Purification ·(unknown), Jeena Middel, Ferenc Jakab, Peter Elfferich, (unknown), (unknown), (unknown), John E. Degener, T H Thé, Ruud M. Scheek, Gjalt W. Welling, Sytske Welling‐Wester	10
12	Comparison of viable cell counts and fluorescence in situ hybridization using specific rRNA-based probes for the quantification of human fecal bacteria 2000 ·FEMS Microbiology Letters ·Hermie J. M. Harmsen, Glenn R. Gibson, Peter Elfferich, (unknown), A. C. M. Wildeboer-Veloo, (unknown), Marcel Roberfroid, G.W. Welling	172
13	RET andGDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems 2000 ·Human Mutation ·Robert M.W. Hofstra, Ying Wu, Rein P. Stulp, Peter Elfferich, (unknown), (unknown), Liesbeth Siderius, (unknown), (unknown), Vera M. R. Heydendael, (unknown), (unknown), Carel Meijers, C.H.C.M. Buys	70
14	Improved mutation detection in GC-rich DNA fragments by combined DGGE and CDGE 1999 ·Nucleic Acids Research ·Ying Wang, (unknown), Peter Elfferich, J. Osinga, Charles H.C.M. Buys, Robert M.W. Hofstra	20
15	A 16S rRNA-targeted Probe for Detection of Lactobacilli and Enterococci in Faecal Samples by FluorescentIn SituHybridization 1999 ·Microbial Ecology in Health and Disease ·Hermie J. M. Harmsen, Peter Elfferich, Frits Schut, Gjalt W. Welling	35
16	16S Ribosomal RNA-Targeted Oligonucleotide Probes for Monitoring of Intestinal Tract Bacteria 1997 ·Scandinavian Journal of Gastroenterology ·G.W. Welling, Peter Elfferich, (unknown), A. C. M. Wildeboer-Veloo, Gijsbert J. Jansen, J. E. Degener	41
17	Altered AP-1/ATF complexes in adenovirus-E1-transformed cells due to EIA-dependent induction of ATF3. 1996 ·PubMed ·(unknown), Monique C.A. Duyndam, Peter Angel, Rolf P. de Groot, (unknown), Peter Elfferich, A.J. van der Eb, A. Zantema	18
18	The N-terminal region of the adenovirus type 5 E1A proteins can repress expression of cellular genes via two distinct but overlapping domains 1995 ·Journal of Virology ·Josephine C. Dorsman, (unknown), Jetty G. Veenstra, Peter Elfferich, (unknown), A. Zantema, A.J. van der Eb	23
19	Rapidc-mycmRNA degradation does not require (A + U)-rich sequences or complete translation of the mRNA 1991 ·Nucleic Acids Research ·Ite A. Laird‐Offringa, Peter Elfferich, A.J. van der Eb	37
20	Poly(A) Tail Shortening Is the Translation-Dependent Step in c- myc mRNA Degradation 1990 ·Molecular and Cellular Biology ·Ite A. Laird‐Offringa, (unknown), Peter Elfferich, Alex J. van der Eb	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact